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Abstract
Mathematical modeling with Ordinary Differential Equations (ODEs) has proven to be
extremely successful in a variety of fields, including biology. However, these models are
completely deterministic given a certain set of initial conditions. We convert mathematical
ODE models of three benchmark biological systems to Dynamic Bayesian Networks (DBNs).
The DBN model can handle model uncertainty and data uncertainty in a principled manner.
They can be used for temporal data mining for noisy and missing variables. We apply Particle
Filtering algorithm to infer the model variables by re-estimating the models parameters of
various biological ODE models. The model parameters are automatically re-estimated using
temporal evidence in the form of data streams. The results show that DBNs are capable of
inferring the model variables of the ODE model with high accuracy in situations where data is
missing, incomplete, sparse and irregular and true values of model parameters are not known.
Introduction
Mathematical models of physical systems are widely available in many domains (Ottesen et al.,
2004). These models embody existing expert knowledge and can be considered sufficient statistics
of all prior experimentation in the domain.
Mathematical modeling with ODEs has a very long tradition in biology. The earliest biological
ODE models date back to 18th century (Malthus, 1798; Verhulst, 1845) . ODE models assume that
the observed dynamics of a system are exclusively driven by internal, deterministic mechanisms
and there is no uncertainty in the process. However, in reality, biological systems are always sub-
ject to ’unexplainable’ influences which are neither easily understood nor is it feasible to model
them explicitly. All biological dynamical systems evolve under stochastic forces. Models of bi-
ological systems are concerned with subsystems of the real world, therefore ideally, they must
include the effect of external random influences as they cannot be completely isolated from model
(Ditlevsen and Samson, 2013). There are many factors in biological processes that are difficult
to model explicitly with ODEs, for example, harmonic oscillations, enzymatic processes, or in-
dividual characteristics like body mass index, genes, lifestyle, habits, age etc. Such factors can
contribute to the erratic behavior in a model. Other factors may include measurement noise or data
uncertainty. These multiple sources of noise need to be modeled explicitly, however, simple ODE
models tend to ignore them, which effects the analysis of the studied biological system and makes
them impractical to be applied to the real world. There is also increasing evidence of stochastic
behavior in critical biological processes, such as gene regulation and cellular behavior. All these
factors point to the possible need to account for stochasticity in mathematical models (Lipniacki
et al., 2006a,b).
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ODE models generally describe population level behaviors. For example, ODE models already
exist to describe the pharmacokinetics and pharmacodynamics of all drugs (see Shargel et al.,
2007). They are developed during clinical trials, published for all approved drugs and used to
determine safe dosage regimes for the average patient. Therefore, parameterization of these models
is generic, typically done in a theoretical manner or based on laboratory or experimental data.
However, the critically ill patient’s unique parameters can vary considerably from those of the
average patient, such population based models often fail to capture specific clinical scenarios.
To describe individuals, model parameters must be re-calibrated using observations of the in-
dividual. However, the observed data may be missing or noisy, or it could sparse or infrequent
relative to the dynamics of the underlying system thus, making individualisation a challenging
task.
Previous research work (Enright and Madden, 2015) in our research group has shown that we
can overcome the limitations of ODE models by mapping them to Dynamic Bayesian Networks
(DBNs) incorporating a first order Euler solver. DBNs are well suited to handle uncertainty and
deal with noisy and missing data. Learning the structure of the DBNs is a challenging task, espe-
cially in situations where data is sparse or incomplete. The expert knowledge available in form of
ODEs can be utilized as ODEs are encapsulated into the DBN structure. DBNs can reason effi-
ciently with this powerful combination of domain knowledge and real time data. They explicitly
model measurement uncertainty and parameter uncertainty, allowing model parameters to be ad-
justed from initial approximate values to their correct values using real-time evidence. By doing
this, the knowledge elicitation bottleneck is bypassed. The technique was previously applied to
the problem of modeling glycaemia in patients in an Intensive Care Unit (Enright et al., 2010),
producing promising results.
We apply the methodology of encapsulating ODE models into DBNs on three small to medium
sized benchmark biological ODE models using the software package PROFET 1 and evaluate the
results of ODE model variable inference and model parameter re-estimation.
1 DBNs for Biological ODE Models
In order to individualize a general biological ODE model to a specific case, we convert it into a
DBN using the software application PROFET. The DBN framework explicitly models noise as
measurement and parameter uncertainty and then reduces the uncertainty over time by individu-
alizing model parameters using temporal evidence. We apply this approach on three benchmark
biological ODE models which were used by Dondelinger et al. (2013) to apply their ODE model
parameter inference methods. We evaluate the results of ODE model variable inference and model
parameter re-estimation on these ODE models; however our experimental setup is different from
that of Dondelinger et al. (2013). The essence of their work is to infer ODE model parameters
from multiple noisy time series data. Our aim is to individualise the model parameters on a single
time series data stream. Therefore, for each ODE model, benchmark data is obtained using the R
package deSolve. The values of the model parameters and the initial state of model variables to
generate the benchmark data are taken from Dondelinger et al. (2013). Instead of adding noise to
the data, we assume that the true values of the ODE model parameters are unknown and must be
inferred from the population values. To discover the correct model parameters, evidence (which
1http://profet.it.nuigalway.ie/
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in these cases are the true values taken from the benchmark solutions) is incorporated. Complete
details of methodology to convert ODE models to DBNs incorporating first order Euler solver can
be found in Enright (2012). Below we describe each model and explain the results.
1.1 The PIF4/5 Model
As described in Dondelinger et al. (2013), this is a model of gene regulation of genes PIF4 and
PIF5 by TOC1 in the ciracadian clock gene regulatory network of Arabidopsis thaliana. The com-
plete network is described by a Locke 2-loop model (Locke et al., 2005). Following Dondelinger
et al. (2013), the model was simplified, such that, the genes PIF4 and PIF5 are combined as
PIF4/5. The DBN created from the PIF4/5 ODE model is shown in Figure 1a. Model parameter
s is the promoter strength, Kd is the rate constant, h represents the Hill coefficient of the regulation
by TOC1 and d is the degradation rate of PIF4/5. PIF4/5 and TOC1 represent the concentra-
tion of the genes. The model parameters are modeled as continuous nodes with linear Gaussian
distribution. The initial state model distribution of the DBN can be viewed as the distribution of
the population. We assume that we do not know the real values of the model parameters but we
only have a rough guess of the population parameters. The true values of the model parameters
must be inferred from the data. Model parameters are allowed to vary in each time step. Evidence
for the observed data is sampled from the benchmark data at different time points. The evidence is
deliberately sampled at sparse and irregular intervals. However, it does not contain any noise.
We run standard fixed time step Particle Filtering algorithm (Gordon et al., 1993) to infer the
values of model parameters and model variables. Figure 2a shows a comparison of benchmark
solution and the predicted solution. It can be seen that even though incorrect values of model
parameters were chosen at the outset, the accuracy of the predicted values of PIF4/5 concentra-
tion begins to improve as evidence is incorporated into the system. The Root Mean Square Error
(RMSE) and Mean Absolute Error (MAE) of the predicted data is 0.070 and 0.035 respectively.
1.2 The Lotka-Volterra Model Predator Prey Model
The Lotka-Volterra model, also known as the predator-prey model is described by two first order,
non linear ODEs. These were first proposed by Edward J. Lotka in 1910 and since then have
been frequently used to describe the dynamics of biological systems in which two species interact,
one as the predator and the other as the prey. The DBN structure corresponding to the ODE
model is shown in Figure 1b. The model variable node X represent the number of prey and
Y represents the number of some predator. Model parameters a, b, c and d are the positive real
numbers that describe the interaction of the two species. This ODE model exhibits periodicity and
the interactions between model variables are non-linear.
(a) (b) (c)
Figure 1: (a) DBN structure of the (a) The PIF4/5 Model (b) The Lotka-Volterra model (c) The Signal
Ttransduction Cascade Model
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We follow the similar steps described in the previous section and run the DBN inference in
time interval [0,2]. Sparse evidence is sampled from the benchmark data of the model variable X .
Graph in Figure 2b shows predicted values of prey population over time. As before, can see that
even though incorrect values of model parameter were chosen at the start, the predicted results are
very close to those of benchmark solution. RMSE and MAE of predicted values of X is 0.287 and
0.137 respectively.
1.3 The Signal Transduction Cascade Model
The model of signal transduction cascade was described in Vyshemirsky and Girolami (2008).
The DBN constructed by PROFET for this ODE model is shown in Figure 1c. The input signal is
represented by the concentration of protein S which can bind to protein R to form a complex RS
which activates protein R into its phosphorylated form Rpp. Protein Rpp can then be de-activated
back to protein R. The model also defines the degradation of input signal, that is, the conversion
of protein S into its degraded form dS. This system represents a realistic formulation of signal
transduction as a mathematical model using mass action and Michaelis-Menten kinetics.
We run the DBN inference in time interval [0,100]. Following Dondelinger et al. (2013), we
sample the evidence of Rpp concentration at more time points during the earlier part of the time
series where the dynamics tend to be faster. In Figure 2c, we plot the value of Rpp concentration
predicted along with the benchmark solution. We can see that the DBN was able to predict the
values of model variable Rpp with high accuracy, even though incorrect model parameters were
chosen in the outset. RMSE and MAE of the predicted data is 0.0085 and 0.0053 respectively.
(a) (b) (c)
Figure 2: Predicted values of model variables in the ODE system. Dashed lines represent the benchmark
solution. Solid lines are the predicted trajectories. Error bars show one standard deviation. Gray dots
are the points where evidence is received. (a) The PIF4/5 model (b) Lotka-Volterra Model (c) The Signal
Transduction Cascade model
Conclusions
This paper has discussed the challenges of applying ODE modeling approaches to real world bi-
ological systems. ODE models are deterministic and they can not account for the uncertainty in
the real world. We proposed to tackle this problem by converting the ODE models to DBNs that
incorporate a first order Euler solver as proposed by Enright et al. (2013). We tested the methodol-
ogy of various biological ODE models. We simulated a real-life situation by assuming that the true
values of the ODE model parameters are not known and data is sparse, incomplete and collected
at irregular intervals. Our DBN framework uses Particle Filtering inference algorithm to infer the
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values of model variables of the ODE model by re-estimating the values of model parameters at
each time step. We have shown that our DBN modeling and inference works well for this task.
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